SCHEMBL4260073

SCHEMBL4260073

COc1nc2ccccc2cc1-c1cccnc1

nearest known ligand 0.73

Predicted protein targets (top 18)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 3/20 0.73
HPGD P15428 1/20 0.73
CYP11B1 P15538 10/20 0.54
CYP11B2 P19099 9/20 0.54
CYP2A6 P11509 1/20 0.53
BTK Q06187 1/20 0.50
GAA P10253 2/20 0.47
TSHR P16473 1/20 0.47
RAB9A P51151 1/20 0.47
HSD17B10 Q99714 1/20 0.47
MEN1 O00255 1/20 0.47
MAPT P10636 1/20 0.47
KMT2A Q03164 1/20 0.47
NPSR1 Q6W5P4 1/20 0.47
PDE10A Q9Y233 1/20 0.47
CYP17A1 P05093 1/20 0.47
CYP19A1 P11511 1/20 0.47
KDM4E B2RXH2 1/20 0.46

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL28905014 0.84 BTK (0.57) ALDH1A1HPGDBTKTSHRRAB9A
SCHEMBL3722968 0.81 CYP11B1 (0.57) ALDH1A1HPGDCYP11B1CYP11B2CYP2A6
Hydrochloric Acid SCHEMBL9847505 0.80 BTK (0.54) ALDH1A1HPGDBTKTSHRRAB9A
SCHEMBL31316504 0.79 BTK (0.50) ALDH1A1HPGDBTKTSHRRAB9A
SCHEMBL4506402 0.78 CYP11B1 (0.60) CYP11B1CYP11B2TSHRRAB9AMAPT
SCHEMBL22509832 0.78 MEN1 (0.58) ALDH1A1HPGDCYP11B1CYP11B2CYP2A6
SCHEMBL15958620 0.78 ALDH1A1 (0.51) ALDH1A1HPGDCYP11B1CYP11B2CYP2A6
SCHEMBL27977365 0.78 CYP11B1 (0.57) ALDH1A1HPGDCYP11B1CYP11B2CYP2A6
SCHEMBL27656250 0.78 CYP11B1 (0.57) ALDH1A1HPGDCYP11B1CYP11B2CYP2A6
SCHEMBL2598829 0.78 CYP11B1 (0.53) ALDH1A1HPGDCYP11B1CYP11B2CYP2A6

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2081931-A2 FUSED HETEROCYCLIC DERIVATIVES USEFUL AS INHIBITORS OF THE HEPATOCYTE GROWTH FACTOR RECEPTOR Amgen Inc. (US) 2009-07-29 EP disclosed
WO-2008008539-A2 FUSED HETEROCYCLIC DERIVATIVES USEFUL AS INHIBITORS OF THE HEPATOCYTE GROWTH FACTOR RECEPTOR AMGEN INC. (US) 2008-01-17 WO disclosed